Respiratory syncytial virus monoclonal antibody RSV mAb nirsevimab Beyfortus age range birth to

By rray, 17 January, 2024
Detail (Long)
<b>Respiratory syncytial virus monoclonal antibody.</b> RSV-mAb (nirsevimab): <a href=https://online.epocrates.com/e/deeplink/drugs/10a11222/Beyfortus%20(nirsevimab-alip)><u>Beyfortus</u></a> (age range: birth to <8 mo; 8-19 mo allowed for certain high-risk groups)